Journal of Genetic Syndromes & Gene Therapy

Journal of Genetic Syndromes & Gene Therapy
Open Access

ISSN: ISSN: 2157-7412

Journal of Genetic Syndromes & Gene Therapy : Citations & Metrics Report

Articles published in Journal of Genetic Syndromes & Gene Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Genetic Syndromes & Gene Therapy has got h-index 23, which means every article in Journal of Genetic Syndromes & Gene Therapy has got 23 average citations.

Following are the list of articles that have cited the articles published in Journal of Genetic Syndromes & Gene Therapy.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Total published articles

15 32 31 25 8 2 1 8 40 28 44 99 43 14

Research, Review articles and Editorials

1 0 3 13 3 1 1 6 20 21 33 69 21 13

Research communications, Review communications, Editorial communications, Case reports and Commentary

14 32 27 9 4 1 0 2 16 7 11 22 4 1

Conference proceedings

0 0 0 0 0 0 61 64 56 0 0 0 52 0

Citations received as per Google Scholar, other indexing platforms and portals

118 167 197 209 211 248 217 322 324 339 198 122 53 21
Journal total citations count 2102
Journal impact factor 5.89
Journal 5 years impact factor 13.25
Journal cite score 20.22
Journal h-index 23
Journal h-index since 2019 16
Important citations (187)

young g (2016) ptsd: traumatic causation. inunifying causality and psychology, springer international publishing.

saracheva k, vasileva l, getova d. world journal of pharmaceutical research.

vagharseyyedin sa (2015. experiences of wives of iranian war veterans with posttraumatic stress disorder regarding social relationships. public health nursing 32: 122-131.

young g (2014) ptsd, endophenotypes, the rdoc, and the dsm-5. psychological injury and law.7: 75-91.

mclaughlin t, oscar-berman m, simpatico t, giordano j, jones s, et al. (2013) hypothesizing repetitive paraphilia behavior of a medication refractive tourette's syndrome patient having rapid clinical attenuation with kb220z-nutrigenomic amino-acid therapy (naat). journal of behavioral addictions 2: 117-124.

sales aj, joca sr (2016) effects of dna methylation inhibitors and conventional antidepressants on mice behaviour and brain dna methylation levels. acta neuropsychiatrica 28: 11-22.

kudryavtseva nn, markel al, orlov yl (2015) aggressive behavior: genetic and physiological mechanisms. russian journal of genetics: appl res 5: 413-429.

martinotti g, sepede g, brunetti m, ricci v, gambi f, et al. (2015) bdnf concentration and impulsiveness level in post-traumatic stress disorder. psychiatry res 229: 814-818.

blum k, thompson b, oscar-berman m, giordano j, braverman e, et al. (2013). genospirituality: our beliefs, our genomes, and addictions. j addict res ther  5.

guerrini i, quadri g, thomson ad (2014) genetic and environmental interplay in risky drinking in adolescents: a literature review. alcohol alcohol 14: agu003.

walsh a, yun i (2014) epigenetics and allostasis: implications for criminology. crim justice rev 39: 411-31.

zisner ar, beauchaine tp (2015) midbrain neural mechanisms of trait impulsivity. oxford handbook of externalizing spectrum disorders1: 184-200.

lindahl m, archer t (2013). depressive expression and anti-depressive protection in adolescence: stress, positive affect, motivation and self-efficacy. psychology 4: 495.

blum k, oscar-berman m, demetrovics z, barh d, gold ms (2014). genetic addiction risk score (gars): molecular neurogenetic evidence for predisposition to reward deficiency syndrome (rds). mol neurobiol 50: 765-96.

thakur c (2016) research & reviews: journal of medical and health sciences.

kumar sr, hoffman be, terhorst c, de jong yp, herzog rw (2017) the balance between cd8+ t cell-mediated clearance of aav-encoded antigen in the liver and tolerance is dependent on the vector dose. mol ther 25.

zolotukhin i, luo d, gorbatyuk os, hoffman be, warrington jr kh, et al. (2013) improved adeno-associated viral gene transfer to murine glioma. j gene syndr gene thera  4.

vercauteren k, hoffman be, zolotukhin i, keeler gd, xiao jw, et al (2016) superior in vivo transduction of human hepatocytes using engineered aav3 capsid. mol therap 24: 1042-1049.

rogers gl, martino at, zolotukhin i, ertl hc, herzog rw (2014) role of the vector genome and underlying factor ix mutation in immune responses to aav gene therapy for hemophilia b. j transl med 12: 25.

barzel a, paulk nk, shi y, huang y, chu k, et al. (2015) promoterless gene targeting without nucleases ameliorates haemophilia b in mice. nature 517: 360-364.

Top